Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

K 13

X
Drug Profile

K 13

Alternative Names: K 13; K13 peptide; SY 007

Latest Information Update: 11 Jan 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Primary Peptides
  • Developer Primary Peptides; Yabao Pharmaceutical Group
  • Class Antithrombotics; Neuroprotectants; Peptides; Vascular disorder therapies
  • Mechanism of Action PTEN inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Stroke

Most Recent Events

  • 10 Jan 2023 K 13 is still in phase I trials for Stroke (In volunteers) in China (NCT04891913) (Primary Peptides pipeline, January 2023)
  • 28 Apr 2022 No recent reports of development identified for phase-I development in Stroke(In volunteers) in China (IV, Injection)
  • 26 May 2020 Suzhou Yabao Pharmaceutical completes a phase I trial in Stroke in China (NCT04111523)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top